Natural product-like MDM2 inhibitors

Natural product-like MDM2 inhibitors

MDM2 inhibition in AML: trial updatesПодробнее

MDM2 inhibition in AML: trial updates

Inhibiting MDM2 to promote apoptosis in ALLПодробнее

Inhibiting MDM2 to promote apoptosis in ALL

Synthesis and Study of Antiproliferative Natural ProductsПодробнее

Synthesis and Study of Antiproliferative Natural Products

MDM2 inhibition in MFПодробнее

MDM2 inhibition in MF

MDM2 inhibitorsПодробнее

MDM2 inhibitors

The Role of p53 and MDM2 in Cancer GrowthПодробнее

The Role of p53 and MDM2 in Cancer Growth

BI 907828: targeting MDM2 in solid tumorsПодробнее

BI 907828: targeting MDM2 in solid tumors

MDM2-p53 antagonist (BI 907828): mechanism of actionПодробнее

MDM2-p53 antagonist (BI 907828): mechanism of action

webinar recording: the Edelris Discovery ENgine (EDEN)Подробнее

webinar recording: the Edelris Discovery ENgine (EDEN)

MDM4/MDM2-p53-IGF1R in nerve regenerationПодробнее

MDM4/MDM2-p53-IGF1R in nerve regeneration

Should we move beyond JAK inhibitors in MPNs?Подробнее

Should we move beyond JAK inhibitors in MPNs?

p53 Tumour Suppressor and MDM2Подробнее

p53 Tumour Suppressor and MDM2

Medical vocabulary: What does Proto-Oncogene Proteins c-mdm2 meanПодробнее

Medical vocabulary: What does Proto-Oncogene Proteins c-mdm2 mean

Making the Problem Go Away: Induced Protein Degradation as a Novel Therapeutic StrategyПодробнее

Making the Problem Go Away: Induced Protein Degradation as a Novel Therapeutic Strategy

Combination of WEE1 inhibition and immunotherapy provides promising preclinical data for SCLCПодробнее

Combination of WEE1 inhibition and immunotherapy provides promising preclinical data for SCLC

p53 in cell cycle regulation | p53 and cancer | p53 tumor suppressor.Подробнее

p53 in cell cycle regulation | p53 and cancer | p53 tumor suppressor.

The two faces of Mdmx: Why some tumors don't respond to radiation and chemotherapyПодробнее

The two faces of Mdmx: Why some tumors don't respond to radiation and chemotherapy

Исследование связи структура-активность ингибиторов взаимодействия Mdm2-p53Подробнее

Исследование связи структура-активность ингибиторов взаимодействия Mdm2-p53

Актуальное